Related Experiment Video

Updated: Dec 30, 2025

Author Spotlight: Unveiling the Role of TMOD3 in Platinum Resistance and Immune Infiltration in Ovarian Cancer
09:40

Author Spotlight: Unveiling the Role of TMOD3 in Platinum Resistance and Immune Infiltration in Ovarian Cancer

Published on: August 2, 2024

3.1K

STAT3 signaling in ovarian cancer: a potential therapeutic target

Renba Liang1, Xishan Chen1, Li Chen1

  • 1Department of Radiation Oncology, Guangxi Medical University Cancer Hospital and Cancer Institute of Guangxi Zhuang Autonomous Region, Nanning, Guangxi, P.R. China.

Journal of Cancer
|January 18, 2020
PubMed

Insights

Signal Transducer and Activator of Transcription 3 (STAT3) is crucial for ovarian cancer progression. Inhibiting STAT3 signaling presents a promising therapeutic strategy for treating this disease.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Research

Background:

  • Signal Transducer and Activator of Transcription 3 (STAT3) is frequently overexpressed in various cancers, promoting tumor progression.
  • STAT3 regulates key cellular processes including tumor growth, survival, invasion, angiogenesis, and drug resistance.

Purpose of the Study:

  • To review the role of STAT3 in ovarian cancer tumorigenesis.
  • To discuss STAT3 signaling inhibitors as potential therapeutic strategies for ovarian cancer.

Main Methods:

  • Literature review focusing on STAT3's role in ovarian cancer.
  • Analysis of existing STAT3 signaling inhibitors.

Main Results:

  • STAT3 overexpression is linked to ovarian cancer progression.
  • STAT3 regulates multiple pathways critical for ovarian cancer development.

Conclusions:

  • STAT3 is a significant driver of ovarian cancer.
  • Targeting STAT3 signaling offers a promising therapeutic avenue for ovarian cancer treatment.
Keywords:
STAT3inhibitorsovarian cancertumorigenesis

More Related Videos

Integration of Bioinformatics Approaches and Experimental Validations to Understand the Role of Notch Signaling in Ovarian Cancer09:08

Integration of Bioinformatics Approaches and Experimental Validations to Understand the Role of Notch Signaling in Ovarian Cancer

Published on: January 12, 2020

7.1K
Evaluating the Angiogenetic Properties of Ovarian Cancer Stem-Like Cells using the Three-Dimensional Co-Culture System, NICO-107:59

Evaluating the Angiogenetic Properties of Ovarian Cancer Stem-Like Cells using the Three-Dimensional Co-Culture System, NICO-1

Published on: December 5, 2020

2.9K

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.5K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
5.1K